Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

IMIQUIMOD

IMIQUIMOD

Standard Dose
5%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview IMIQUIMOD is listed in Drugs@FDA under application 202002 (ANDA).

Marketing status: Discontinued Active ingredient IMIQUIMOD Form and strength CREAM;TOPICAL - 5% Sponsor STRIDES PHARMA Submission history Latest submission status date: 2014-06-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview IMIQUIMOD is listed in Drugs@FDA under application 202002 (ANDA). Marketing status: Discontinued Active ingredient IMIQUIMOD Form and strength CREAM;TOPICAL - 5% Sponsor STRIDES PHARMA Submission history Latest submission status date: 2014-06-24 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.